Targeted therapy in KITD816V-positive mastocytosis: waiting for proof-of-principle.
Tefferi
Ayalew
A
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA. tefferi.ayalew@mayo.edu
Pardanani
Animesh
A
D049109:Cell Proliferation; D006801:Humans; D034721:Mastocytosis, Systemic / Q000235:genetics* / Q000628:therapy*; D009154:Mutation; D010641:Phenotype; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics*; D012871:Skin Diseases / Q000628:therapy; D016896:Treatment Outcome
D019009:Proto-Oncogene Proteins c-kit